Mark S. Gaunya Company Profile

12:41 EDT 23rd September 2018 | BioPortfolio

News Articles [351 Associated News Articles listed on BioPortfolio]

OptraSCAN secures CE mark for whole-slide scanners for in-vitro diagnostics use

The CE Mark will allow OptraSCAN’s scanners to be sold in countries belonging to or affiliated to European Union (EU) that recognizes CE mark. OptraSCAN’s On-Demand desktop scanning The post Optr...

Bionow announced as a winner of the Northwest Cluster Mark

The 'Cluster Mark' is a new national initiative by central government being introduced to support the UK Manufacturing Strategy and as such is primarily aimed at recognising manufacturing excellence. ...

Training in UV Spectroscopy

Mark Powell Scientific Limited has been selected by Spectroscopy Magazine to write and deliver an on-line training course in UV spectroscopy. The course covers theory, instrumentation, qualitative an...

Dexcom G6 CGM System Receives CE Mark

Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up. A...

Kleresca gets CE mark for next generation Biophotonic system in dermatology

For Kleresca, the CE mark approval is the foundation for future expansion in both Europe, US, Canada and Australia. It confirms that the product meets the requirements of The post Kleresca gets CE ma...

Kleresca secures CE mark for biophotonic dermatological system

For Kleresca, the CE mark approval is the foundation for future expansion in both Europe, US, Canada and Australia. It confirms that the product meets the requirements of The post Kleresca secures CE...

Sen. Mark Warner: Facebook Not Being Fully Forthcoming About Data Leak

Sen. Mark Warner (D-Va.), the senior Democrat on the Senate Intelligence

Body of Missing St. Joseph's University Freshman Mark Dombroski Found in Bermuda

Mark Dombroski, 19, was last seen at a bar called The Dog House.

PubMed Articles [229 Associated PubMed Articles listed on BioPortfolio]

Epigenetic and redox biomarkers: Novel insights from the MARK-AGE Study.

Ageing is a multifactorial process that affects most, if not all, of the body's tissues and organs and can be defined as the accumulation of physical and psychological changes in a human being over ti...

Right TKR Patients Treated with Enhanced Pain and Rehabilitation Protocols Can Drive at 2 Weeks.

An important milestone in the recovery following total knee replacement (TKR) is the ability to return to driving. With advances in pain control and the widespread introduction of rapid rehab programs...

Professor Mark Caulfield.

Building a better MUNIX: New and improved, but does it hit the mark?

Considering the numbers.

Clinical Trials [98 Associated Clinical Trials listed on BioPortfolio]

Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

Convenience and preference for the new Mark VII pen compared to the current Genotropin pen will be assessed using a questionaire. it is expected that the new pen will be preferred or at l...

HeartMate 3 CE Mark Study Long Term Follow-up

The purpose of this clinical investigation is to report the long term survival and incidence of adverse events in the patients who were implanted with HM3 in the CE Mark Study and continue...

An Age-Stratified Data Collection Study in Adult Males and Females, Ages 18 and Above to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

To collect three dimensional retinal measurements of the optic disc and the macula lutea on healthy normal subjects using the 3D OCT-1000 Mark II for the purpose of developing a normative ...

User Evaluation Study of SyncVision System With Software v4.X

This is a prospective, single-arm, unblinded, case observation study evaluating a pre-release 'Conformité Européenne' (CE)-mark co-registration software system along-side of a commercial...

Neonatal Outcomes in Instrumental Delivery

The aim of this study is to compare the impact of instrumental delivery on newborn head mark and newborn comfort over the impact of non-instrumental delivery. It is also to evaluate how mo...

Companies [174 Associated Companies listed on BioPortfolio]

Mark S. Gaunya

Dr. Mark Lynn & Associates PLLC

Dr. Mark Lynn & Associates PLLC, or Mark Lynn O.D. & Associates PC, owns and/or operates more than 50 Dr. Bizer’s Vision World, Dr. Bizer’s ValuVision, Doctor’s Val...

J. A. Kemp and Company

The firm includes over 30 qualified European Patent Attorneys, U.K. Chartered Patent Attorneys and Trade Mark Attorneys as well as solicitors. The breadth of expertise and experience of the Partners, ...

Mark Farrah Associates (MFA)

MFA is a leading data aggregator and publisher providing health plan market data and analysis tools for the healthcare industry. Committed to simplifying analysis of health insura...


In 1960, Mark Hume McCormack shook hands with a young golfer named Arnold Palmer. That historic handshake established a legendary empire that would evolve into today's IMG, the world's premier sports...

More Information about "Mark S. Gaunya" on BioPortfolio

We have published hundreds of Mark S. Gaunya news stories on BioPortfolio along with dozens of Mark S. Gaunya Clinical Trials and PubMed Articles about Mark S. Gaunya for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mark S. Gaunya Companies in our database. You can also find out about relevant Mark S. Gaunya Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record